Platelet-derived growth factor subunit A (PDGFA) mRNA (PDGFA mRNA)

Platelet-derived growth factor subunit A (PDGFA) mRNA is the messenger RNA transcript that encodes the alpha polypeptide of the PDGF family. This transcript is translated into the PDGFA protein, which typically forms the PDGF-AA homodimer or PDGF-AB heterodimer to signal through the PDGFR-alpha receptor. Biologically, PDGFA is a potent mitogen and chemoattractant for mesenchymal cells, playing a critical role in organogenesis, wound healing, and the maintenance of connective tissue. In disease states, the overexpression of PDGFA mRNA is frequently observed in various cancers, including glioblastoma and sarcomas, where it drives autocrine and paracrine signaling to promote tumor growth and stroma recruitment. It is also heavily implicated in fibrotic diseases, such as liver and lung fibrosis, by stimulating the activation and proliferation of myofibroblasts. As a therapeutic target, PDGFA mRNA is addressed using RNA-based technologies like small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) designed to induce transcript degradation or inhibit translation. These approaches aim to reduce the production of the pro-proliferative PDGF-AA protein at the source, offering a precise method to modulate the PDGF signaling pathway in hyperproliferative and fibrotic conditions.

Other names

Platelet-derived growth factor A-chain mRNAPDGF-A mRNAPDGF1 mRNAPlatelet-derived growth factor alpha polypeptide mRNA

RNA interference (siRNA-mediated cleavage), RNase H-mediated degradation (ASO), and translation inhibition to prevent the synthesis of the PDGFA protein.